Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens
- PMID: 28446572
- PMCID: PMC5483913
- DOI: 10.1128/JCM.00181-17
Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens
Abstract
Bloodstream infections (BSI) are an important cause of morbidity and mortality. Increasing rates of antimicrobial-resistant pathogens limit treatment options, prompting an empirical use of broad-range antibiotics. Fast and reliable diagnostic tools are needed to provide adequate therapy in a timely manner and to enable a de-escalation of treatment. The Accelerate Pheno system (Accelerate Diagnostics, USA) is a fully automated test system that performs both identification and antimicrobial susceptibility testing (AST) directly from positive blood cultures within approximately 7 h. In total, 115 episodes of BSI with Gram-negative bacteria were included in our study and compared to conventional culture-based methods. The Accelerate Pheno system correctly identified 88.7% (102 of 115) of all BSI episodes and 97.1% (102 of 105) of isolates that are covered by the system's identification panel. The Accelerate Pheno system generated an AST result for 91.3% (95 of 104) samples in which the Accelerate Pheno system identified a Gram-negative pathogen. The overall category agreement between the Accelerate Pheno system and culture-based AST was 96.4%, the rates for minor discrepancies 1.4%, major discrepancies 2.3%, and very major discrepancies 1.0%. Of note, ceftriaxone, piperacillin-tazobactam, and carbapenem resistance was correctly detected in blood culture specimens with extended-spectrum beta-lactamase-producing Escherichia coli (n = 7) and multidrug-resistant Pseudomonas aeruginosa (n = 3) strains. The utilization of the Accelerate Pheno system reduced the time to result for identification by 27.49 h (P < 0.0001) and for AST by 40.39 h (P < 0.0001) compared to culture-based methods in our laboratory setting. In conclusion, the Accelerate Pheno system provided fast, reliable results while significantly improving turnaround time in blood culture diagnostics of Gram-negative BSI.
Keywords: antimicrobial susceptibility testing; bloodstream infections; rapid tests.
Copyright © 2017 American Society for Microbiology.
Similar articles
-
Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures.Microbiol Spectr. 2021 Dec 22;9(3):e0183621. doi: 10.1128/Spectrum.01836-21. Epub 2021 Dec 22. Microbiol Spectr. 2021. PMID: 34937177 Free PMC article.
-
Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.J Clin Microbiol. 2018 Mar 26;56(4):e01672-17. doi: 10.1128/JCM.01672-17. Print 2018 Apr. J Clin Microbiol. 2018. PMID: 29386262 Free PMC article.
-
Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1573-1583. doi: 10.1007/s10096-018-3287-6. Epub 2018 May 28. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29808350
-
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications.Clin Microbiol Infect. 2020 Jun;26(6):713-722. doi: 10.1016/j.cmi.2019.09.023. Epub 2019 Oct 11. Clin Microbiol Infect. 2020. PMID: 31610299 Review.
-
Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis.Clin Microbiol Infect. 2020 Mar;26(3):271-280. doi: 10.1016/j.cmi.2019.11.009. Epub 2019 Nov 18. Clin Microbiol Infect. 2020. PMID: 31751768
Cited by
-
Metabolic preference assay for rapid diagnosis of bloodstream infections.Nat Commun. 2022 Apr 28;13(1):2332. doi: 10.1038/s41467-022-30048-6. Nat Commun. 2022. PMID: 35484129 Free PMC article.
-
Susceptibility Testing by Volatile Organic Compound Detection Direct from Positive Blood Cultures: A Proof-of-Principle Laboratory Study.Antibiotics (Basel). 2022 May 24;11(6):705. doi: 10.3390/antibiotics11060705. Antibiotics (Basel). 2022. PMID: 35740111 Free PMC article.
-
Microplate-based surface area assay for rapid phenotypic antibiotic susceptibility testing.Sci Rep. 2019 Jan 18;9(1):237. doi: 10.1038/s41598-018-35916-0. Sci Rep. 2019. PMID: 30659207 Free PMC article.
-
Evaluation of two rapid molecular test systems to establish an algorithm for fast identification of bacterial pathogens from positive blood cultures.Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1147-1157. doi: 10.1007/s10096-020-03828-5. Epub 2020 Feb 4. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32020397 Free PMC article.
-
Rapid antibiotic susceptibility testing of bacteria from patients' blood via assaying bacterial metabolic response with surface-enhanced Raman spectroscopy.Sci Rep. 2020 Jul 27;10(1):12538. doi: 10.1038/s41598-020-68855-w. Sci Rep. 2020. PMID: 32719444 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical